Mirena® (Levonorgestrel intrauterine system): A successful novel drug delivery option in contraception

Advanced Drug Delivery Reviews

Volumn 61, Issue 10, 2009, Pages 808-812

  Rose, Susan ^a   Chaudhari, Angela ^a   Peterson, C Matthew ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Contraception; Copper T IUD; Endometrial hyperplasia; Intrauterine device; Menorrhagia; Progesterone

Indexed keywords

CONTRACEPTION; ENDOMETRIAL HYPERPLASIA; INTRAUTERINE DEVICE; MENORRHAGIA; PROGESTERONE;

DRUG DELIVERY;

LIQUEFIED NATURAL GAS;

COPPER INTRAUTERINE DEVICE; DIMETICONE; ESTROGEN; GESTAGEN; LEVONORGESTREL; PROGESTERONE; TAMOXIFEN; CONTRACEPTIVE AGENT;

ACNE; ADENOMYOSIS; BLEEDING; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG RELEASE; DRUG SAFETY; DRUG TISSUE LEVEL; DYSMENORRHEA; ECTOPIC PREGNANCY; ENDOMETRIUM HYPERPLASIA; FEMALE FERTILITY; HORMONAL CONTRACEPTION; HUMAN; LOW DRUG DOSE; MENORRHAGIA; MENSTRUATION; OVARY CYST; PAIN; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; CONTRACEPTION; DRUG ADMINISTRATION; FEMALE; GYNECOLOGIC DISEASE; INTRAUTERINE CONTRACEPTIVE DEVICE; INTRAVAGINAL DRUG ADMINISTRATION; MENSTRUATION DISORDER; PATIENT SATISFACTION;

ADMINISTRATION, INTRAVAGINAL; CONTRACEPTION; CONTRACEPTIVE AGENTS, FEMALE; DRUG ADMINISTRATION SCHEDULE; DRUG DELIVERY SYSTEMS; FEMALE; GENITAL DISEASES, FEMALE; HUMANS; INTRAUTERINE DEVICES, MEDICATED; LEVONORGESTREL; MENSTRUATION DISTURBANCES; PATIENT SATISFACTION;

EID: 67649207600     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2009.04.022     Document Type: Review

References (49)

1. Henshaw S.K. Unintended pregnancy in the United States. Fam. Plann. Perspect. 30 (1998) 24-29 46
2. Ortho Pharmaceutical Corp. Annual Birth Control Study. Raritan, NJ: Ortho Pharmaceutical Corp (1998)
3. Hatcher R.A., Stewart F., Trussell J., et al. Contraceptive technology 1990-1992 (1994), Irvington Publishers, New York
4. Trussell J., and Vaughan B. Contraceptive failure, method-related discontinuation and resumption of use: results from the 1995 National Survey of Family Growth. Fam. Plann. Perspect. 31 (1999) 64-72
5. Hillard P.J.A. The patient's reaction to side effects of oral contraceptives. Am. J. Obstet. Gynecol. 161 (1989) 1412-1415
6. Andersson K. The levonorgestrel intrauterine system: more than a contraceptive. Eur. J. Contracept. Reprod. Health Care 6 Suppl 1 (2001) 15-22
7. ® intrauterine progesterone contraception system. A new look at IUDs-advancing contraceptive choices. In: Bardi C.W.B., and Mishell Jr. D.R. (Eds). Fourth Conference on IUDs (1992), Butterwords-Heinemann, Boston 319-327
8. Andersson K., Mattsson L.A., Rybo G., and Stadberg E. Intrauterine release of levonorgestrel-a new way of adding progestogen in hormone replacement therapy. Obstet. Gynecol. 79 (1992) 963-967
9. Nilsson C.G., Luukkainen T., and Lahteenmaki P. Determination of plasma concentrations of d-norgestrel during a 1 year follow-up in women with a d-norgestrel-releasing IUD. Contraception 17 (1978) 569-573
10. Nilsson C.G., Lahteenmaki P., Robertson D.N., and Luukkainen T. Plasma concentrations of levonorgestrel as a function of the release rate of levonorgestrel from medicated intrauterine devices. Acta Endocrinol. (Copenhagen) 93 (1980) 38-40
11. Nilsson C.G., Lahteenmaki P., and Luukkainen T. Patterns of ovulation and bleeding with a low levonorgestrel-releasing intrauterine device. Contraception 21 (1980) 155-164
12. Nilsson C.G., Lahteenmaki P., and Luukkainen T. Levonorgestrel plasma concentrations and hormone profiles after insertion and after 1 year of treatment with a levonorgestrel-IUD. Contraception 21 (1980) 225-233
13. Nilsson C.G., Haukkamaa M., and Luukkainen T. Tissue concentrations of levonorgestrel in women using a levonorgestrel-releasing IUD. Clin. Endocrinol. 17 (1982) 529-536
14. Nilsson C.G., Luukkainen T., and Arko H. Endometrial morphology in women using a d-norgestrel-releasing IUD. Fertil. Steril. 29 (1978) 397-401
15. Weiner E., and Johansson E.B.D. Plasma levels of d-norgestrel, estradiol and progesterone during treatment with silastic implants containing d-norgestrel. Contraception 14 (1976) 81-92
16. Toivonen J., Lahteenmaki P., and Luukkainen T. Bleeding and ovulation control with use of a small contraceptive vaginal ring releasing levonorgestrel and estradiol. Contraception 20 (1979) 11-18
17. French R., and Gullebaud J. Mirena, the levonorgestrel intra-uterine system (20 ug/day). J. Drug Evaluation 1 2 (2003) 43-69
18. Sivin I. Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants. Drug Safety 26 5 (2003) 303-335
19. Andersson K., Odlind V., and Rybo G. Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during 5 years of use: a randomized comparative trial. Contraception 49 1 (1994) 56-72
20. Critchley H.O., Wang H., Jones R.L., Kelly R.W., Drudy T.A., Gebbie A.E., et al. Morphological and functional features of endometrial decidualization following long-term intrauterine levonorgestrel delivery. Hum. Reprod. 13 (1998) 1218-1224
21. Mandelin E., Koistinen H., Koistinen R., Affandi B., and Seppala M. Levonorgestrel-releasing intrauterine device-wearing women express contraceptive glycodelin A in endometrium during midcycle: another contraceptive mechanism?. Hum. Reprod. 12 (1997) 2671-2675
22. Luukainen T., Lahteenmaki P., and Toivonen J. Levonorgestrel-releasing intrauterine device. Ann. Med. 22 2 (1990) 85-90
23. Gullebaud J. The levonorgestrel intrauterine system: a clinical perspective from the U.K. Ann. N.Y. Acad. Sci. 997 (2003) 185-193
24. Sivin I. Protective effect of intrauterine release of levonorgestrel on pelvic infection: 3 years' comparative experience of levonorgestrel- and copper-releasing intrauterine devices. Obstet. Gynecol. 77 (1991) 960-961
25. Barbosa I., Olsson S.E., Odlind V., Goncalves T., and Coutinho E. Ovarian function after 7 years' use of a levonorgestrel IUD. Adv. Contracept. 11 (1995) 85-95
26. Increasing access to IUDs. In: Grimes D. (Ed). The Contraception Report (1998) 9
27. Mirena (LNG IUS) [package insert]. Montvale (2000), Berlex Laboratories, Inc, NJ
28. French R.S., Cowan F.M., Mansour D., Higgins J.P., Robinson A., Procter T., et al. Levonorgestrel-releasing (20 μg/day) intrauterine systems (Mirena) compared with other methods of reversible contraceptives. BJOG 107 (2000) 1218-1225
29. Backman T., Huhtala S., Blom T., Luoto R., Rauramo I., and Koskenvuo M. Length of use and symptoms associated with premature removal of the levonorgestrel intrauterine system: a nation-wide study of 17,360 users. BJOG 107 (2000) 335-339
30. Luukkainen T., Pakarinen P., and Toivonen J. Progestin-releasing intrauterine systems. Semin. Reprod. Med. 19 (2001) 355-363
31. Jensen J.T. Noncontraceptive applications of the levonorgestrel intrauterine system. Curr. Womens Health Rep. 2 (2002) 417-422
32. Ronnerdag M., and Odlind V. Health effects of long-term use of the intrauterine levonorgestrel-releasing system: a follow-up study over 12 years of continuous use. Acta Obstet. Gynecol. Scand. 78 (1999) 716-721
33. Ikomi A., and Pepra E.F. Efficacy of the levonorgestrel intrauterine system in treating menorrhagia: actualities and ambiguities. J. Fam. Plann. Reprod. Health Care 28 (2002) 99-100
34. Lahteenmaki P., Haukkamaa M., Puolakka J., Riikonen U., Sainio S., Suvisaari J., et al. Open randomized study of use of levonorgestrel releasing intrauterine system as alternative to hysterectomy. BMJ 316 (1998) 1122-1126
35. Nagrani R., Bowen-Simpkins P., and Barrington J.W. Can the levonorgestrel intrauterine system replace surgical treatment for the management of menorrhagia?. BJOG 109 (2002) 345-347
36. Vercellini P., Aimi G., Panazza S., De Giorgi O., Pesole A., and Crosignani P.G. A levonorgestrel-releasing intrauterine system for the treatment of dysmenorrhea associated with endometriosis: a pilot study. Fertil. Steril. 72 (1999) 505-508
37. Ikomi A., and Pepra E.F. Efficacy of the levonorgestrel intrauterine system in treating menorrhagia: actualities and ambiguities. J. Fam. Plann. Reprod. Health Care 28 (2002) 99-100
38. Lahteenmaki P., Haukkamaa M., Puolakka J., Riikonen U., Sainio S., Suvisaari J., et al. Open randomized study of use of levonorgestrel releasing intrauterine system as alternative to hysterectomy. BMJ 316 (1998) 1122-1126
39. Jarvela I., Tekay A., and Jouppila P. The effect of a levonorgestrel releasing intrauterine system on uterine artery blood flow, hormone concentrations and ovarian cyst formation in fertile women. Hum. Reprod. 13 (1998) 3379-3383
40. Andersson K., Batar I., and Rybo G. Return to fertility after removal of a levonorgestrel-releasing intrauterine device and Nova-T. Contraception 46 (1992) 575-584
41. French R.S., Cowan F.M., Mansour D., Higgins J.P., Robinson A., Procter T., et al. Levonorgestrel-releasing (20 μg/day)intrauterine systems (Mirena) compared with other methods of reversible contraceptives. BJOG 107 (2000) 1218-1225
42. Luukkainen T., Allonen H., Haukkamaa M., Lahteenmaki P., Nilsson C.G., and Toivonen J. Five years' experience with levonorgestrel-releasing IUDs. Contraception 5 (1986) 139-148
43. Nilsson C.G., Luukkainen T., Diaz J., and Allonen H. Intrauterine contraception with levonorgestrel: a comparative randomized clinical performance study. Lancet 1 Pt 1 (1981) 577-580
44. Wollter-Svensson L.O., Stadberg E., Andersson K., et al. Intrauterine administration of levonorgestrel in two low doses in HRT administration. Maturitas 22 (1995) 199-205
45. Raudaskoski T., Tapanainen J., Tomas E., Luotola H., Pekonen F., Ronni-Sivula H., Timonen H., Riphagen F., and Laatikainen T. Intrauterine 10 ug and 20 ug levonorgestrel systems in postmenopausal women receiving oral oestrogen replacement therapy: clinical, endometrial, metabolic response. Br. J. Obstet. Gynecol. 109 (2002) 136-144
46. Birkhauser M.H. New routes of HRT administration. Int. J. Fertil. 43 (1998) 206-207
47. Wildmeersch D., Schacht E., Wildemeersch P., Janssens D., and Thiery M. Development of a miniature, frameless intrauterine levonorgestrel-releasing system for contraception and treatment: a review of initial clinical experience. Reprod. BioMed. 4 (2001) 69-80. http://www.rbmonline.com (www.rbmonline.com)
48. Wu S., Hu J., and Wildemeersch D. Performance of the frameless gyneFix and the TCu380A IUDs in a 3 year multicenter randomized comparative trial in parous women. Contraception 61 (2000) 91-99
49. Andrews G.D., French K., and Wilkinson C.L. Appropriately trained nurses are competent at inserting intrauterine devices: an audit of clinical practice. Contraceptive Choices and Realities. In: van Lunsen R.H.W., Unzeitig V., and Creatas G. (Eds). Proceedings of the 5th Congress of the European Society of Contraception (2000), The Parthenon Publishing Group, London 160-163